Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia
Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, Heba Elhusseini, Harika Nalluri, Thomas Kaiser, Sivapriya Ramamoorthy, Shernan G Holtan, Alexander Khoruts, Daniel J Weisdorf, Christopher Staley, Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, Heba Elhusseini, Harika Nalluri, Thomas Kaiser, Sivapriya Ramamoorthy, Shernan G Holtan, Alexander Khoruts, Daniel J Weisdorf, Christopher Staley
Abstract
Despite antibiotic prophylaxis, most patients with acute leukemia receiving mucotoxic chemotherapy develop neutropenic fever (NF), many cases of which remain without a documented etiology. Antibiotics disrupt the gut microbiota, with adverse clinical consequences, such as Clostridioides difficile infection. A better understanding of NF pathogenesis could inform the development of novel therapeutics without deleterious effects on the microbiota. We hypothesized that metabolites absorbed from the gut to the bloodstream modulate pyrogenic and inflammatory pathways. Longitudinal profiling of the gut microbiota in 2 cohorts of patients with acute leukemia showed that Akkermansia expansion in the gut was associated with an increased risk for NF. As a prototype mucolytic genus, Akkermansia may influence the absorption of luminal metabolites; thus, its association with NF supported our metabolomics hypothesis. Longitudinal profiling of the serum metabolome identified a signature associated with gut Akkermansia and 1 with NF. Importantly, these 2 signatures overlapped in metabolites in the γ-glutamyl cycle, suggesting oxidative stress as a mediator involved in Akkermansia-related NF. In addition, the level of gut microbial-derived indole compounds increased after Akkermansia expansion and decreased before NF, suggesting their role in mediating the anti-inflammatory effects of Akkermansia, as seen predominantly in healthy individuals. These results suggest that Akkermansia regulates microbiota-host metabolic cross talk by modulating the mucosal interface. The clinical context, including factors influencing microbiota composition, determines the type of metabolites absorbed through the gut barrier and their net effect on the host. Our findings identify novel aspects of NF pathogenesis that could be targets for precision therapeutics. This trial was registered at www.clinicaltrials.gov as #NCT03316456.
© 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Figures
References
- Sickles EA, Greene WH, Wiernik PH.. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med. 1975;135(5):715-719.
- Hansen B-A, Wendelbo Ø, Bruserud Ø, Hemsing AL, Mosevoll KA, Reikvam H.. Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment. Mediterr J Hematol Infect Dis. 2020;12(1):e2020009.
- Bucaneve G, Micozzi A, Menichetti F, et al. ; Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Infection Program . Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005;353(10):977-987.
- Peseski AM, McClean M, Green SD, Beeler C, Konig H.. Management of fever and neutropenia in the adult patient with acute myeloid leukemia. Expert Rev Anti Infect Ther. 2021;19(3):359-378.
- Gyssens IC, Kern WV, Livermore DM; ECIL-4, a joint venture of EBMT, EORTC, ICHS and ESGICH of ESCMID .The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients. Haematologica. 2013;98(12):1821-1825.
- Spellberg B. The new antibiotic mantra - “shorter is better”. JAMA Intern Med. 2016;176(9):1254-1255.
- Belkaid Y, Harrison OJ.. Homeostatic immunity and the microbiota. Immunity. 2017;46(4):562-576.
- Belkaid Y, Hand TW.. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-141.
- Galloway-Peña JR, Shi Y, Peterson CB, et al. . Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia. Clin Infect Dis. 2020;71(1):63-71.
- Rashidi A, Kaiser T, Shields-Cutler R, et al. . Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia. Sci Rep. 2019;9(1):6083.
- Rashidi A, Kaiser T, Graiziger C, et al. . Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy. Leukemia. 2020;34(1):312-316.
- Wikoff WR, Anfora AT, Liu J, et al. . Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA. 2009;106(10):3698-3703.
- Visconti A, Le Roy CI, Rosa F, et al. . Interplay between the human gut microbiome and host metabolism. Nat Commun. 2019;10(1):4505.
- Derrien M, Vaughan EE, Plugge CM, de Vos WM.. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(Pt 5):1469-1476.
- Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM.. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol. 2008;74(5):1646-1648.
- Rashidi A, Kaiser T, Graiziger C, et al. . Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation. Cancer. 2020;126(7):1434-1447.
- Freifeld AG, Bow EJ, Sepkowitz KA, et al. ; Infectious Diseases Society of America . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56-e93.
- Benjamini Y, Hochberg Y.. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289-300.
- Segata N, Izard J, Waldron L, et al. . Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.
- Keizer RJ, Jansen RS, Rosing H, et al. . Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses. Pharmacol Res Perspect. 2015;3(2):e00131.
- Leong HS, Kipling D. Text-based over-representation analysis of microarray gene lists with annotation bias. Nucleic Acids Res. 2009;37(11):e79.
- van den Berg RA, Hoefsloot HCJ, Westerhuis JA, Smilde AK, van der Werf MJ.. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics. 2006;7(1):142.
- Ridlon JM, Harris SC, Bhowmik S, Kang D-J, Hylemon PB.. Consequences of bile salt biotransformations by intestinal bacteria [published correction appears in Gut Microbe. 2016; 7(3):262]. Gut Microbes. 2016;7(1):22-39.
- Smith EA, Macfarlane GT.. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol. 1996;81(3):288-302.
- Sumner LW, Amberg A, Barrett D, et al. . Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics. 2007;3(3):211-221.
- Mair RD, Sirich TL, Plummer NS, Meyer TW.. Characteristics of colon-derived uremic solutes. Clin J Am Soc Nephrol. 2018;13(9):1398-1404.
- Lees HJ, Swann JR, Wilson ID, Nicholson JK, Holmes E.. Hippurate: the natural history of a mammalian-microbial cometabolite. J Proteome Res. 2013;12(4):1527-1546.
- Depommier C, Everard A, Druart C, et al. . Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103.
- Everard A, Belzer C, Geurts L, et al. . Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013;110(22):9066-9071.
- Ballatori N, Krance SM, Marchan R, Hammond CL. Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med. 2009;30(1-2):13-28.
- Zhang H, Forman HJ.. Redox regulation of γ-glutamyl transpeptidase. Am J Respir Cell Mol Biol. 2009;41(5):509-515.
- Mardinoglu A, Shoaie S, Bergentall M, et al. . The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol Syst Biol. 2015; 11(10):834.
- Suzuki H, Hashimoto W, Kumagai H.. Escherichia coli K-12 can utilize an exogenous gamma-glutamyl peptide as an amino acid source, for which gamma-glutamyltranspeptidase is essential. J Bacteriol. 1993;175(18):6038-6040.
- Suzuki H, Kumagai H, Tochikura T.. gamma-Glutamyltranspeptidase from Escherichia coli K-12: formation and localization. J Bacteriol. 1986;168(3):1332-1335.
- Alam A, Leoni G, Wentworth CC, et al. . Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and requires formyl peptide receptor 1. Mucosal Immunol. 2014;7(3):645-655.
- Jones RM, Luo L, Ardita CS, et al. . Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J. 2013;32(23):3017-3028.
- Neish AS, Jones RM.. Redox signaling mediates symbiosis between the gut microbiota and the intestine. Gut Microbes. 2014;5(2):250-253.
- Dinarello CA. Cytokines as endogenous pyrogens. J Infect Dis. 1999;179(suppl 2):S294-S304.
- Reuter S, Schnekenburger M, Cristofanon S, et al. . Tumor necrosis factor α induces γ-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Biochem Pharmacol. 2009;77(3):397-411.
- Riedel W, Maulik G.. Fever: an integrated response of the central nervous system to oxidative stress. Mol Cell Biochem. 1999;196(1-2):125-132.
- Hou C-C, Lin H, Chang C-P, Huang W-T, Lin M-T.. Oxidative stress and pyrogenic fever pathogenesis. Eur J Pharmacol. 2011;667(1-3):6-12.
- Roager HM, Licht TR.. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9(1):3294.
- Schirmer M, Smeekens SP, Vlamakis H, et al. . Linking the human gut microbiome to inflammatory cytokine production capacity [published correction appears in Cell. 2016;167(7):1897]. Cell. 2016;167(4):1125-1136.e8.
- Wlodarska M, Luo C, Kolde R, et al. . Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation. Cell Host Microbe. 2017;22(1):25-37.e6.
- Png CW, Lindén SK, Gilshenan KS, et al. . Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105(11):2420-2428.
- Koropatkin NM, Cameron EA, Martens EC.. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol. 2012;10(5):323-335.
- Verhoog S, Taneri PE, Roa Díaz ZM, et al. . Dietary factors and modulation of bacteria strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: a systematic review. Nutrients. 2019;11(7):1565.
- Desai MS, Seekatz AM, Koropatkin NM, et al. . A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(5):1339-1353.e21.
- Ribera J-M, Oriol A, Morgades M, et al. . Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial. J Clin Oncol. 2014;32(15):1595-1604.
- Chalandon Y, Thomas X, Hayette S, et al. ; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) . Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia [published correction appears in Blood. 2015;126(10):1261]. Blood. 2015;125(24):3711-3719.
Source: PubMed